Type 2 Diabetes Clinical Trial
Official title:
Evaluation of the Effect of Pomegranate Peel on Plasma Glucose, Lipid Parameters, and Lipid Oxidation in Individuals With Type 2 Diabetes: A Randomized Controlled Study
Verified date | February 2022 |
Source | Toros University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate the effects of the consumption of bread produced with the addition of pomegranate peels, which has a high antioxidant content, on blood glucose and lipid parameters, and some oxidant-antioxidant enzymes and lipid peroxidation in individuals with type 2 diabetes.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | June 1, 2022 |
Est. primary completion date | April 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 64 Years |
Eligibility | Inclusion Criteria: - Being diagnosed with type 2 diabetes for at least 5 years, - Using only oral antidiabetic - With a Body Mass Index (BMI) value = 25.0 kg/m2, - Signing the Informed Voluntary Consent Form, - Being in an age range of 19-64 years. Exclusion Criteria: - Having kidney, liver, and inflammatory diseases, - Being on insulin therapy, - Using prescription drugs and/or fiber supplements, - Taking vitamin and mineral supplements, - Being pregnant/lactating, - Consuming excessive alcohol (>2 drinks/day), - Being in the menstrual period, - Receiving gluten enteropathy, - Having allergy against pomegranate. - In addition, individuals with Covid-19-related condition during the study process will be excluded from the study. |
Country | Name | City | State |
---|---|---|---|
Turkey | Özlem ÖZPAK AKKUS | Mersin | Yenisehir |
Lead Sponsor | Collaborator |
---|---|
Toros University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Biochemical Blood Parameters | Examination of between group differences regarding lipid profile | First day at the beginning of the study | |
Primary | Biochemical Blood Parameters | Examination of between group differences regarding HbA1c | First day at the beginning of the study | |
Primary | Biochemical Blood Parameters | Examination of between group differences regarding insulin | First day at the beginning of the study | |
Primary | Biochemical Blood Parameters | Examination of between group differences regarding TAC | First day at the beginning of the study | |
Primary | Biochemical Blood Parameters | Examination of between group differences regarding TBARS | First day at the beginning of the study | |
Primary | Anthropometric Measurements - Weight | Examination of between group differences regarding weight in kilogram | First day at the beginning of the study | |
Primary | Anthropometric Measurements - Height | Examination of between group differences regarding height in meter | First day at the beginning of the study | |
Primary | Anthropometric Measurements - Body Mass Index | Examination of between group differences regarding body mass index (BMI = weight in kilogram / height in meter 2) | First day at the beginning of the study | |
Primary | Anthropometric Measurements - Waist Circumference | Examination of between group differences regarding waist circumference in centimeters | First day at the beginning of the study | |
Primary | Anthropometric Measurements - Hip Circumference | Examination of between group differences regarding hip circumference in centimeters | First day at the beginning of the study | |
Secondary | Biochemical Blood Parameters | Comparison of between group differences regarding lipid profile | Eight weeks after the start of the study | |
Secondary | Biochemical Blood Parameters | Comparison of between group differences regarding HbA1c | Eight weeks after the start of the study | |
Secondary | Biochemical Blood Parameters | Comparison of between group differences regarding insulin | Eight weeks after the start of the study | |
Secondary | Biochemical Blood Parameters | Comparison of between group differences regarding TAC | Eight weeks after the start of the study | |
Secondary | Biochemical Blood Parameters | Comparison of between group differences regarding TBARS | Eight weeks after the start of the study | |
Secondary | Anthropometric Measurements - Weight | Examination of between group differences regarding weight in kilogram | Eight weeks after the start of the study | |
Secondary | Anthropometric Measurements - Height | Examination of between group differences regarding height in meter | Eight weeks after the start of the study | |
Secondary | Anthropometric Measurements - Body Mass Index | Examination of between group differences regarding body mass index (BMI = weight in kilogram / height in meter 2) | Eight weeks after the start of the study | |
Secondary | Anthropometric Measurements - Waist Circumference | Examination of between group differences regarding waist circumference in centimeters | Eight weeks after the start of the study | |
Secondary | Anthropometric Measurements - Hip Circumference | Examination of between group differences regarding hip circumference in centimeters | Eight weeks after the start of the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |